Advertisement

The subjective/objective dichotomy in schizophrenia - relevance to nosology, research and management

  • A. G. Awad
  • L. N. P. Voruganti

Abstract

In the 1960s, when psychobiological research gained momentum, admirable concerted efforts were made to move psychiatry into the scientific discipline it deserves being. Efforts were made to standardize observations and diagnoses by developing rating scales and classificatory systems. That commendable push was accomplished with a price. Several researchers and clinicians lamented the decline in interest in subjective phenomena. Van Praag [9] made a serious and passionate plea for the reconquest of the subjective. Others warned the psychiatric field that, by ignoring the subjective experiences of our patients, descriptive psychiatry could be seriously limited as well as our ability to understand and optimally manage our patients [1, 8].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Awad AG (1993) Subjective response to neuroleptics in schizophrenia. Schizophrenia Bulletin 19: 609–618PubMedCrossRefGoogle Scholar
  2. 2.
    Awad AG, Hogan TP, Voruganti LNP, Heslegrave RJ (1995) Patients’ subjective experiences on antipsychotic medications: implications for outcome and quality of life. International Clinical Psychopharmacology 10(Suppl 3): 123–132PubMedGoogle Scholar
  3. 3.
    Heslegrave RJ, Awad AG, Voruganti LNP (1997) The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. Journal of Psychiatry and Neurosciences 22: 235–243Google Scholar
  4. 4.
    Hogan TP, Awad AG (1992) Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychological Medicine 22: 347–352PubMedCrossRefGoogle Scholar
  5. 5.
    Hogan TP, Awad AG, Eastwood MR (1983) A self-report scale predictive of drug compliance in schizophrenia, reliability and discriminative ability. Psychological Medicine 13: 177–183PubMedCrossRefGoogle Scholar
  6. 6.
    Husserl E (1973) Experience and Judgement. Northwestern University Press, Evanston, 111. USAGoogle Scholar
  7. 7.
    Schwartz MA, Wiggins OP (1987) Typifications: the first step for clinical diagnosis in psychiatry. Journal of Nervous and Mental Disease 175: 65–77PubMedCrossRefGoogle Scholar
  8. 8.
    Strauss JS (1989) Subjective experiences of schizophrenia: towards a new dynamic psychiatry. Schizophrenia Bulletin 15: 178–179Google Scholar
  9. 9.
    van Praag HM (1992) Reconquest of the subjective. British Journal of Psychiatry 160: 266–271PubMedCrossRefGoogle Scholar
  10. 10.
    Voruganti LNP, Heslegrave RJ, Awad AG (1997) Neuroleptic dysphoria may be the missing link between schizophrenia and substance abuse. The Journal of Nervous and Mental Disease 185: 463–465PubMedCrossRefGoogle Scholar
  11. 11.
    Voruganti LNP, Heslegrave RJ, Awad AG, Seeman MV (1998) Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychological Medicine 28: 165–172PubMedCrossRefGoogle Scholar
  12. 12.
    Voruganti LNP, Slomka P, Zabel P, Costa G, So A, Mattar A, Awad AG (2001) Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dys-phoric responses and striatal D2 binding ratios on SPCT imaging. Neuropsychopharma-cology 25: 642–650Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • A. G. Awad
  • L. N. P. Voruganti

There are no affiliations available

Personalised recommendations